Lucid Group

Brilliant healthcare science does not create change by itself: it must be translated into clear decisions, stakeholder belief and real-world action. Lucid Group addresses this challenge by bringing together scientific rigour, behavioural insight, commercial ingenuity, creative storytelling and strategic foresight. The global healthcare communications partner works across the asset lifecycle, helping pharmaceutical, biotechnology and healthcare organisations shape products into brands, build clinical consensus, align launch pathways and accelerate adoption. Its work spans strategy consulting, scientific and medical communications, commercial communications, connected intelligence and AI-powered solutions.

Founded by leaders with pharmaceutical and biotechnology experience, Lucid has spent more than two decades turning complex evidence into practical outcomes. The company reports more than 400 specialists worldwide, including scientists, strategists, communication experts and innovation specialists, and says it has supported more than 100 launches across demanding healthcare categories. Lucid uses behavioural insight, advanced analytics and AI to reduce friction, sharpen strategy and move stakeholders from understanding to action, with the ultimate aim of changing clinical practice and improving patient outcomes.